Neuroblastoma
FEATURES
avatar
450 clinical trials
avatar
288 cell line models
avatar
5 approved drugs
IMAGE
Neuroblastoma
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

5 drugs have received FDA approval for Neuroblastoma:

  • BuMel
  • Cyclophosphamide
  • Dinutuximab
  • Doxorubicin Hydrochloride
  • Vincristine Sulfate

147 drugs have a clinical trial registered for Neuroblastoma.

781 compounds have been tested in Neuroblastoma (547 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 450 clinical trials for Neuroblastoma, 316 of which have one or more drug interventions, 134 with no drug intervention.
Cell line models

There are 288 Cell Line Models for Neuroblastoma.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Neuroblastoma:
  • Ganglioneuroblastoma
  • Esthesioneuroblastoma, Olfactory
  • Neuroblastoma
The following terms have been mapped from cancer.gov to Neuroblastoma:
  • Neuroblastoma that is high risk. It is used in children who had at least a partial response to other drugs and other types of treatment
  • Neuroblastoma
  • Neuroblastoma that is high risk. It is used to prepare patients for a stem cell transplant